GE HealthCare target raised, added to ‘Tactical Outperform’ list at Evercore ISI

Evercore ISI raised the firm’s price target on GE HealthCare to $92 from $90 and keeps an Outperform rating on the shares, which the analyst is also adding to the firm’s “Tactical Outperform” list ahead of earnings from the MedTech, Life Science Tools and Diagnostics group. Evercore has “a distinct bias towards mega caps and value/GARP as we head into” Q2, the analyst tells investors.